| Citation: |
LI Yang, ZHANG Yuxiang, ZHANG Rongfang. Diagnostic value of exhaled nitric oxide, alveolar nitric oxide and eosinophils in respiratory diseases among children aged 3 to 6 years[J]. Journal of Clinical Medicine in Practice, 2024, 28(6): 74-78. DOI: 10.7619/jcmp.20233615
|
To investigate the application value of fractional exhaled nitric oxide (FeNO), alveolar nitric oxide (CaNO), and eosinophils (EOS) in the differential diagnosis of respiratory diseases in children aged 3 to 6 years in Lanzhou, Gansu Province.
A total of 360 children aged 3 to 6 years with confirmed asthma, allergic rhinitis, or lower respiratory tract infection were selected as research subjects. Spearman's rank correlation coefficient was used to evaluate the correlation between FeNO, CaNO and EOS. The diagnostic value of FeNO, CaNO, and EOS for the differential diagnosis of the three diseases was assessed through random forest models, receiver operating characteristic (ROC) curves, and multivariate Logistic regression analysis.
The median valuesof FeNO and CaNO were higher in asthmatic children than in those with other diseases. The median value of EOS was the lowest in children with allergic rhinitis, and the median values of FeNO and CaNO were the lowest in children with lower respiratory tract infection. Correlation analysis showed a positive correlation between FeNO and CaNO (r=0.59, P < 0.05), a negative correlation between FeNO and EOS (r=-0.61, P < 0.05), and a negative correlation between CaNO and EOS (r=-0.63, P < 0.05). The random forest model indicated that FeNO had the highest importance in disease classification. ROC curve analysis revealed that FeNO, CaNO, and EOS had the highest diagnostic efficiency for lower respiratory tract infection among the three diseases (with areas under the curve of 0.86, 0.91, and 1.00, respectively). The area under the curve of the multivariate Logistic regression model for diagnosing asthma was 0.96, with a sensitivity of 0.902 and a specificity of 0.881.
FeNO, CaNO and EOS demonstrate good potential in the differential diagnosis of asthma, allergic rhinitis, and lower respiratory tract infection in children aged 3 to 6 years in Lanzhou. Furthermore, the multivariate Logistic regression model based on these three factors can effectively improve the diagnostic accuracy of asthma.
| [1] |
洪建国. 我国儿童哮喘流行病学和诊治状况[J]. 中华医学信息导报, 2020, 35(2): 22-22.
|
| [2] |
WISE S K, DAMASK C, ROLAND L T, et al. International consensus statement on allergy and rhinology: Allergic rhinitis-2023[J]. Int Forum Allergy Rhinol, 2023, 13(4): 293-859.
|
| [3] |
ZHU H Y, HAO C L, YU X M, et al. Fractional exhaled nitric oxide (FeNO) integrating airway hyperresponsiveness (AHR) examination promotes etiologic diagnosis and treatment for children with chronic cough[J]. Med Sci Monit, 2021, 27: e928502.
|
| [4] |
CELIS-PRECIADO C A, LACHAPELLE P, COUILLARD S. Exhaled nitric oxide (FeNO): bridging a knowledge gap in asthma diagnosis and treatment[J]. Clin Exp Allergy, 2023, 53(8): 791-793. doi: 10.1111/cea.14374
|
| [5] |
BARAÑSKI K, ZEJDA J E. Screening accuracy of FeNO measurement for childhood asthma in a community setting[J]. Children, 2022, 9(6): 858. doi: 10.3390/children9060858
|
| [6] |
SCHNEIDER A, FADERL B, SCHWARZBACH J, et al. Prognostic value of bronchial provocation and FENO measurement for asthma diagnosis: results of a delayed type of diagnostic study[J]. Respir Med, 2014, 108(1): 34-40. doi: 10.1016/j.rmed.2013.11.008
|
| [7] |
李芮, 董晓艳, 蒋鲲, 等. 口鼻呼出气一氧化氮检测在儿童支气管哮喘控制评估及过敏性鼻炎诊断中的应用[J]. 中国当代儿科杂志, 2022, 24(1): 90-95. https://www.cnki.com.cn/Article/CJFDTOTAL-DDKZ202201013.htm
|
| [8] |
SCHNEIDER A, BRUNN B, HAPFELMEIER A, et al. Diagnostic accuracy of FeNO in asthma and predictive value for inhaled corticosteroid responsiveness: a prospective, multicentre study[J]. EClinicalMedicine, 2022, 50: 101533. doi: 10.1016/j.eclinm.2022.101533
|
| [9] |
MUNTEAN I A, BOCSAN I C, VESA S, et al. Could FeNO predict asthma in patients with house dust mites allergic rhinitis[J]. Medicina, 2020, 56(5): 235. doi: 10.3390/medicina56050235
|
| [10] |
NAKWAN N, THIDARAT RUKLERD T, PERKLEANG T, et al. The levels and correlations of FeNO, blood eosinophils and lung function in well-controlled asthma[J]. Adv Respir Med, 2022, 90(3): 183-192. doi: 10.5603/ARM.a2022.0015
|
| [11] |
高永伟. 呼出气一氧化氮检测在小儿支气管哮喘早期诊断及病情评估中的应用[J]. 实用临床医药杂志, 2020, 24(3): 90-93. doi: 10.7619/jcmp.202003026
|
| [12] |
LIPWORTH B, KUO C R, CHAN R. 2020 Updated Asthma Guidelines: clinical utility of fractional exhaled nitric oxide (Feno) in asthma management[J]. J Allergy Clin Immunol, 2020, 146(6): 1281-1282. doi: 10.1016/j.jaci.2020.03.006
|
| [13] |
WANG J, WANG W T, LIN H, et al. Role of pulmonary function and FeNO detection in early screening of patients with ACO[J]. Exp Ther Med, 2020, 20(2): 830-837.
|
| [14] |
任莉, 杨俊. 呼出气一氧化氮在儿童哮喘管理中的临床价值[J]. 实用临床医药杂志, 2022, 26(5): 96-99. doi: 10.7619/jcmp.20214064
|
| 1. |
岳佳丽，海光，雷卓颖，王丽君. 环硅酸锆钠联合肾素-血管紧张素-醛固酮系统抑制剂治疗慢性肾脏病的机制和效果的研究进展. 中国医药导报. 2024(16): 188-190 .
| |
| 2. |
竹琳，郑浩天，万正红，何莉，周莉. 血液透析患者高钾血症相关领域研究热点及发展动态的可视化分析. 华西医学. 2024(08): 1259-1264 .
| |
| 3. |
黄湘干，赵艳，关毅标，翁春亮，谢双燕. 维持性血液透析患者高钾血症发生的相关因素分析. 现代医学与健康研究电子杂志. 2024(21): 116-119 .
| |
| 4. |
董生荣，景舒梦，苟伟康，房浩亮，刘彬彬，刘永峰. 环硅酸锆钠治疗围透析期患者慢性高钾血症的有效性研究. 中国卫生标准管理. 2023(02): 140-143 .
| |
| 5. |
陈丽，常文秀. 环硅酸锆钠散治疗慢性肾脏病高钾血症的临床研究. 现代诊断与治疗. 2023(05): 700-703 .
| |
| 6. |
陈文文，方芦炜，丁越越，马红珍. 马红珍教授治疗慢性肾病伴高钾血症的中药应用策略. 浙江中医药大学学报. 2023(08): 874-879 .
| |
| 7. |
蔡享兰. 不同剂量肾康注射液辅助治疗慢性肾脏病3～5期的效果及对肾功能的影响. 中国医学创新. 2023(30): 49-53 .
| |
| 8. |
宋欣芫，常文秀. 慢性肾脏病5期合并高钾血症饮食干预1例报告. 中国实用内科杂志. 2022(05): 438-440 .
| |
| 9. |
张灿，王静. 慢性肾脏疾病患者血钾异常的影响因素及对预后的影响研究. 医药论坛杂志. 2022(13): 20-23 .
| |
| 10. |
刘环，罗琰琨，王晨丹. 环硅酸锆钠散治疗慢性高钾血症1例. 中国医药. 2022(12): 1877-1879 .
| |
| 11. |
丁苗佳，沈水娟，吴佳盈. 新型口服降钾药物环硅酸锆钠治疗慢性肾脏病高钾血症临床进展. 中国医药科学. 2021(21): 66-69 .
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: